# Angiotensin 2 for AKI After OLT

> **NCT04592744** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **University of California, Los Angeles** · enrollment: 30 (estimated)

## Conditions studied

- Cirrhosis, Liver
- End Stage Liver DIsease
- Acute Kidney Injury
- Liver Transplant; Complications

## Interventions

- **DRUG:** Angiotensin II
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT04592744
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-04-08
- **Primary completion:** 2025-12
- **Final completion:** 2026-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592744, "Angiotensin 2 for AKI After OLT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04592744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*